Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DR until

NAV on October 01, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets ₹1,565 cr
Turnover Ratio 65.05%
Expense Ratio 1.00%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: Negative return: -4.29%
  • 1Y: Positive return: 7.81%
  • 3M: Negative return: -0.15%
  • 3Y: Positive return: 18.23%
  • 6M: Positive return: 15.09%
  • 5Y: Positive return: 13.99%
Min Investment ₹5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since about 2 years)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 40.58
P/B Ratio 6.28
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 99.5%
  • Debt: 0.5%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.77
Beta 0.99
R-Squared 93.17
Info Ratio -0.29
Tracking Err 4.28
Sortino 1.209
Sharpe 0.734
Std Dev 16.735
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.51%
Industrial 0.0%
Technology 0.0%
Basic Materials 7.07%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 91.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.09%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
₹ 51.144 20.26% ₹ 3,555 cr 0.61% -
₹ 584.618 20.19% ₹ 5,796 cr 1.04% -
₹ 378.650 16.65% ₹ 1,444 cr 1.26% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata